AbCellera Biologics
Innovator in antibody discovery for therapeutics, and immune profiling for vaccine research. Learn more
Launch date
Employees
Market cap
€717m
Enterprise valuation
€173m (Public information from Sep 2024)
Share price
$2.74 ABCL
Vancouver British Columbia (HQ)
Authorizing premium user...